177 related articles for article (PubMed ID: 38589870)
1. A case of autoimmune pulmonary alveolar proteinosis during the course of treatment of rapidly progressive interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositis.
Yatomi M; Akasaka K; Sato S; Chida M; Kanbe M; Sawada H; Yokota I; Wakamatsu I; Muto S; Sato M; Yamaguchi K; Miura Y; Tsurumaki H; Sakurai R; Hara K; Koga Y; Sunaga N; Yamakawa H; Matsushima H; Yamazaki S; Endo Y; Motegi SI; Hisada T; Maeno T
BMC Pulm Med; 2024 Apr; 24(1):170. PubMed ID: 38589870
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune pulmonary alveolar proteinosis exacerbated by steroid therapy due to misdiagnosis as anti-aminoacyl-tRNA synthetase (ARS) antibody positive- interstitial pneumonia: a case report.
Ishimoto H; Sakamoto N; Yura H; Hara A; Kido T; Yamaguchi H; Yamamoto K; Obase Y; Ishimatsu Y; Satoh M; Mukae H
BMC Pulm Med; 2022 Mar; 22(1):120. PubMed ID: 35361191
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report.
Sato S; Akasaka K; Ohta H; Tsukahara Y; Kida G; Tsumiyama E; Kusano K; Oba T; Nishizawa T; Kawabe R; Yamakawa H; Amano M; Matsushima H; Takada T
BMC Pulm Med; 2020 Apr; 20(1):84. PubMed ID: 32252718
[TBL] [Abstract][Full Text] [Related]
4. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
[TBL] [Abstract][Full Text] [Related]
5. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
[No Abstract] [Full Text] [Related]
6. Anti-MDA5 Antibody-positive Dermatomyositis with Rapidly Progressive Interstitial Pneumonia Presenting with Nephrotic Syndrome during Treatment with Corticosteroids and Cyclosporine.
Kawamoto S; Abe T; Nagahori K; Yoshino A; Fujii A; Ono Y; Ueda Y; Takeda T
Intern Med; 2022 Jul; 61(13):2007-2012. PubMed ID: 34776485
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.
Endo Y; Koga T; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kuwana M; Hosono Y; Mimori T; Kawakami A
Medicine (Baltimore); 2018 Jun; 97(26):e11024. PubMed ID: 29952940
[TBL] [Abstract][Full Text] [Related]
8. Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report.
Watanabe T; Takizawa N; Nagasaka T; Nakamura Y; Ikai H; Yamamoto M; Murai Y; Takasugi K; Yokoyama-Kokuryo W; Fujita Y
Medicine (Baltimore); 2020 Jan; 99(3):e18600. PubMed ID: 32011440
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.
Arai T; Kasai T; Shimizu K; Kawahara K; Katayama K; Sugimoto C; Hirose M; Okamoto H; Tachibana K; Akira M; Inoue Y
Intern Med; 2020 Oct; 59(20):2539-2546. PubMed ID: 32611952
[TBL] [Abstract][Full Text] [Related]
10. Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody.
Isoda K; Kotani T; Takeuchi T; Kiboshi T; Hata K; Ishida T; Otani K; Kamimori T; Fujiwara H; Shoda T; Makino S
Rheumatol Int; 2017 Aug; 37(8):1335-1340. PubMed ID: 28451794
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.
Endo Y; Koga T; Suzuki T; Hara K; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kuwana M; Kawakami A
Medicine (Baltimore); 2018 Apr; 97(15):e0436. PubMed ID: 29642214
[TBL] [Abstract][Full Text] [Related]
12. Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease.
Imura Y; Yukawa N; Handa T; Nakashima R; Murakami K; Yoshifuji H; Ohmura K; Ishii H; Nakata K; Mimori T
Mod Rheumatol; 2018 Jul; 28(4):724-729. PubMed ID: 26872621
[TBL] [Abstract][Full Text] [Related]
13. Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis Presenting as Refractory Gingivitis at the First Clinical Manifestation.
Kawakami E; Uchida T; Iwamoto N; Hara K; Egashira K; Kawakami A
Intern Med; 2024 Jan; 63(1):131-134. PubMed ID: 37197957
[TBL] [Abstract][Full Text] [Related]
14. Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review.
Yeung TW; Cheong KN; Lau YL; Tse KN
Pediatr Rheumatol Online J; 2021 Jun; 19(1):103. PubMed ID: 34193210
[TBL] [Abstract][Full Text] [Related]
15. [Dermatomyositis associated with anti-MDA5 antibodies and pneumocystis pneumonia: Two lethal cases].
Aymonier M; Abed S; Boyé T; Barazzutti H; Fournier B; Morand JJ
Ann Dermatol Venereol; 2017 Apr; 144(4):279-283. PubMed ID: 27839728
[TBL] [Abstract][Full Text] [Related]
16. Successful Rescue Therapy With Daratumumab in Rapidly Progressive Interstitial Lung Disease Caused by MDA5-Positive Dermatomyositis.
Holzer MT; Nies JF; Oqueka T; Huber TB; Kötter I; Krusche M
Chest; 2023 Jan; 163(1):e1-e5. PubMed ID: 36628678
[TBL] [Abstract][Full Text] [Related]
17. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
Matsushita T; Mizumaki K; Kano M; Yagi N; Tennichi M; Takeuchi A; Okamoto Y; Hamaguchi Y; Murakami A; Hasegawa M; Kuwana M; Fujimoto M; Takehara K
Br J Dermatol; 2017 Feb; 176(2):395-402. PubMed ID: 27452897
[TBL] [Abstract][Full Text] [Related]
18. Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis.
Fujita Y; Fukui S; Suzuki T; Ishida M; Endo Y; Tsuji S; Takatani A; Igawa T; Shimizu T; Umeda M; Sumiyoshi R; Nishino A; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Abe K; Kawakami A
Intern Med; 2018 Dec; 57(23):3473-3478. PubMed ID: 29984753
[TBL] [Abstract][Full Text] [Related]
19. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K
Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum anti-GM-CSF autoantibody levels in autoimmune pulmonary alveolar proteinosis.
Nishimura M; Yamaguchi E; Takahashi A; Asai N; Katsuda E; Ohta T; Ohtsuka Y; Kosaka K; Matsubara A; Tanaka H; Yokoe N; Kubo A; Konno S; Baba K
Biomark Med; 2018 Feb; 12(2):151-159. PubMed ID: 29202602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
